Zhi-Heng Chen (2021) “Serological Thymidine Kinase1 is a Biomarker for Early Risk of Tumours Progression —Real World Data from a Health Screening Study on a Cohort of 35,365 People”, Newest Updates in Physical Science Research Vol. 5, pp. 36–65. doi: 10.9734/bpi/nupsr/v5/1960F.